Journal of Basic and Clinical Pharmacy received 14978 citations as per google scholar report
Interstitial lung disease is one of the most chronic inflammatory conditions that progressively can affect pulmonary function and patient quality of life. Tyrosine kinase inhibitors are novel medicinal agents that play a role reducing disease progression. We report a case of an acute myocardial infarction that may have been associated with the use of nintedanib; a tyrosine kinase inhibitor.